Email: rachel.a.elliott@manchester.ac.uk

Research profile and key clinical specialties

I am a pharmacist and a health economist. I use trials, large databases and routine data and economic modelling in complex healthcare problems with high patient and economic burden, including patient safety and medicines-taking.

My work has informed national health policy in the UK and other countries. I am currently looking at the change in use of digital and remote technology since COVID. 

I am a member of a NICE technology appraisal committee. I am Senior Methods Lead, NIHR Research Design Service NW.

Two key publications

• Elliott RA et al. Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice. Pharmacoeconomics 2017; 35:1237-1255 DOI: 10.1007/s40273-017-0554-9. PMID: 28776320
• Elliott RA, et al. Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Quality & Safety. 2021;30:96-105. dx.doi.org/10.1136/bmjqs-2019-010206

Possible PhD projects

• Economic impact of digital health interventions in mental health
• Economic impact of digital health interventions to improve medicines-taking in long-term conditions

More information

• Manchester Centre for Health Economics
• Twitter: @RachelElliott67
• ORCID
• ResearchGate

Keywords: Pharmacist, medicines, databases, economics, patient, safety, Pharmacoeconomics, Rachel, Elliott, Manchester

Related